The effect of bradykinin on afferent cardiac sympathetic nerve fibers has been examined. Using anesthetized dogs, the action potentials of the fi bers were derived from either the 2nd or 3rd thoracic communicating ramus of the left side. Excitation of the afferent fibers was observed following administration of bradykinin acetate dissolved in physiological saline on the left ventricular wall. The minimum concentration required for excitation was 50-100ng/ml. The fibers were excited rhythmically synchronous with myocardial contraction and/or relaxation. However, no significant augmentation of myocardial contraction was produced by the agent. Bradykinin-induced excitation of the fibers was significantly reduced by pretreatment with acetylsalicylic acid. The results suggest bradykinininduced sensitization of the receptor sites of the afferent fibers for normal modality of left ventricular motion. 2) This substance is the most powerful of all the algesic agents.
METHODS

Observations
traction and relaxation for the remaining preparations. Application of the solutions of over 10ng/ml also caused a slight fall in systemic blood pressure (Fig.2) . However, no significant change in left ventricular tension was produced by application of the solutions to the ventricular surface. Application of the solutions was carried out in 28 nerve preparations in which tapping of the ventricular wall could not evoke the action potentials. Solutions of 100 and 500ng/ml provoked the action potentials in 2 of these preparations. Although their conduction time was not measured, their rhythmical appearance had a close relation to each cardiac beat.
In 5 nerve preparations, the effect of pretreatment with acetylsalicylic acid on bradykinin-induced excitation was examined. A dose of 100-150 mg/Kg was used since the pseudaffective response elicited by intra-coronary injections of bradykinin can be blocked by a dose of over 100mg/Kg.1), 17) The maximum firing rate was reduced below 50 percent of the control value in Jap. Heart J. January, 1974 all these preparations. The latency for the inhibitory effect was 10-15min (Table II) . stitial space and the occluded artery may be increased much more since the blood which drains from the ischemic wall into the coronary sinus may be diluted by the blood from the non-ischemic area. Therefore, there is a possibility that bradykinin participates in ischemia-induced excitation10) of the afferent cardiac sympathetic nerve fibers.
In this study, all of the fibers, irrespective of their response to topical mechanical stimuli, were activated by bradykinin. In addition, myocardial contraction and/or relaxation were found to be responsible for their activation. On the other hand, no significant augmentation of left ventricular contraction measured by a strain gauge arch was produced by the agent. Consequently, it is likely that bradykinin sensitized the nerve endings so that the normal intensities of myocardial motion excited the endings.
Antipyretic agents act as competitive antagonists and occupy the receptor sites.17) The agents have been found to block the splenic nerves to bradykinin19) and the pseudaffective response elicited by intra-coronary injections of bradykinin.18) In this study, acetylsalicylic acid suppressed excitation of the afferent fi bers. The latency for its inhibitory effect was the same as that for blocking the bradykinin-induced pseudaffective response. 18) Following topical application of bradykinin, the somatic reactions such as extension of the limbs and disappearance of shudder occurred in addition to the changes in blood pressure and respiration. These reactions can be attributed to bradykinin-induced excitation of the afferent cardiac sympathetic nerves since the vagal afferent nerves had been transected.
Bradykinin administration produces cutaneous and vascular pain in man as well as the pseudaffective response in animals. With those results together with the observations made by Gutzman and Furukawa, it is interesting to speculate that kinins or bradykinin may participate in mechanism for production of anginal pain, in which excitation of the afferent cardiac sympathetic nerves is currently understood in relation to ischemia. However, definite evidence which supports this view still lacks.
